source
- STAT+: Online GLP-1 prescriptions are often fast, easy — and low on clinical oversightA new secret-shopper study found that GLP-1 prescriptions from telehealth sites aren't often backed by appropriate clinical care.STAT · 25d ago↗ source
- Gene editing developer Scribe plots an IPOThe California drugmaker, which has collaborations in place with Biogen, Sanofi and Eli Lilly, could be the 14th biotech to go public in 2026.BioPharma Dive · 25d ago↗ source
- Novartis to acquire ADC developer in a deal worth up to $1.5BThe deal hands over two ADCs with a different mechanism of action targeting cell growth, and marks Novartis' entry into ADC development.BioPharma Dive · 25d ago↗ source